Thyrocare Technologies Limited

NSEI:THYROCARE 株式レポート

時価総額:₹52.0b

Thyrocare Technologies マネジメント

マネジメント 基準チェック /24

Thyrocare Technologiesの CEO はRahul Guhaで、 May2022年に任命され、 の在任期間は 2.5年です。 の年間総報酬は₹ 35.00Mで、 40%給与と60%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.1%を直接所有しており、その価値は₹ 52.72M 。経営陣と取締役会の平均在任期間はそれぞれ1.9年と2.8年です。

主要情報

Rahul Guha

最高経営責任者

₹35.0m

報酬総額

CEO給与比率40.0%
CEO在任期間2.5yrs
CEOの所有権0.1%
経営陣の平均在職期間1.9yrs
取締役会の平均在任期間2.8yrs

経営陣の近況

Recent updates

Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Oct 31
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Aug 01
Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Jul 26
Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Jun 12
A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Feb 29
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 04
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Dec 08
Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 08
Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Mar 23
Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Mar 02
Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Feb 01
Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

Jan 12
Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Dec 24
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Dec 17
Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 30
Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Nov 02
Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

Nov 01
Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

CEO報酬分析

Thyrocare Technologies の収益と比較して、Rahul Guha の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

₹840m

Jun 30 2024n/an/a

₹776m

Mar 31 2024₹35m₹14m

₹708m

Dec 31 2023n/an/a

₹655m

Sep 30 2023n/an/a

₹648m

Jun 30 2023n/an/a

₹599m

Mar 31 2023₹32mn/a

₹645m

報酬と市場: Rahulの 総報酬 ($USD 414.68K ) は、 Indian市場 ($USD 359.99K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Rahulの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Rahul Guha (46 yo)

2.5yrs

在職期間

₹35,000,004

報酬

Mr. Rahul Franklin Guha serves as President of Operations at API Holdings Limited since 2024. He is Managing Director, Chief Executive Officer and Director of Thyrocare Technologies Limited from May 04, 20...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Rahul Guha
MD, CEO & Chairman2.5yrs₹35.00m0.10%
₹ 52.7m
Alok Jagnani
Chief Financial Officer1.3yrs₹5.55mデータなし
K. KallathiKumar
Chief Operating Officerno data₹9.32m0.0030%
₹ 1.6m
Ramjee Dorai
Company Secretary & Compliance Officer10.2yrs₹3.64m0.040%
₹ 20.8m
Pratik Hire
Head of Strategy & Investor Relationsno dataデータなしデータなし
Nitin Chugh
Chief Commercial Officerless than a yearデータなしデータなし
Aditya Shinde
Vice Presidentno data₹5.33m0.0020%
₹ 1.0m
Kapil Gupta
Strategy Managerno dataデータなしデータなし

1.9yrs

平均在職期間

46yo

平均年齢

経験豊富な経営陣: THYROCAREの経営陣は 経験豊富 とはみなされません ( 1.9年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Rahul Guha
MD, CEO & Chairman2.5yrs₹35.00m0.10%
₹ 52.7m
Indumati Gopinathan
Non-Executive Independent Director7.3yrs₹240.00kデータなし
Dharmil Sheth
Non-Executive & Non-Independent Director3.2yrsデータなしデータなし
Hardik Dedhia
Non Executive Director3.2yrsデータなしデータなし
Dhaval Shah
Non Executive Director3.1yrsデータなしデータなし
Prapti Gilada
Independent Director1.3yrs₹220.00kデータなし
Harshil Vora
Non-Executive Independent Director1.3yrs₹40.00kデータなし
Anandh Sundar
Independent Directorno dataデータなしデータなし
Nishant Shah
Independent Directorless than a yearデータなしデータなし

2.8yrs

平均在職期間

36yo

平均年齢

経験豊富なボード: THYROCAREの 取締役会経験豊富 ではない ( 2.8年の平均在任期間) ため、新しい取締役会が必要であると考えられます。